Standout Papers

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B... 2005 2026 2012 2019 1.1k
  1. Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B (2005)
    George Lau, Teerha Piratvisuth et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 10 from Science/Nature 78 standout
Sub-graph 1 of 17

Citing Papers

Human assembloid model of the ascending neural sensory pathway
2025 StandoutNature
Cancer Statistics, 2021
2021 Standout
2 intermediate papers

Works of Philip McCloud being referenced

EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial
2014
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
2005 Standout

Author Peers

Author Last Decade Papers Cites
Philip McCloud 196 1728 311 1600 674 51 3.6k
Deloris E. Koziol 129 968 398 415 222 69 3.1k
Alessandra Vitelli 186 2328 36 2037 239 54 4.3k
Anastasia Makris 34 1162 1434 1060 577 41 3.5k
A Moriarty 276 2188 117 405 193 27 5.8k
Teruki Miyake 299 1221 38 677 570 183 3.8k
Francine Walker 175 1181 271 216 341 87 3.7k
Marco Carli 326 1389 54 542 203 96 7.7k
Gisele Zandman‐Goddard 292 800 77 237 353 141 6.1k
Bernard Charpentier 401 727 145 385 135 105 5.5k
Vera Pravica 433 888 119 339 121 83 4.4k

All Works

Loading papers...

Rankless by CCL
2026